pharma · Cerebral adrenoleukodystrophy (cALD) · Adrenoleukodystrophy
Minoryx Therapeutics
Minoryx Therapeutics S.L.
Minoryx Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
ES HQ
2011 Founded
32 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- ES
- Founded
- 2011
- Employees
- 32
- Programs
- 4
- Drugs
- 11
- Patents
- 0
Minoryx Therapeutics projects
1 ClinicalTrials.gov programs sponsored by Minoryx Therapeutics.
Minoryx Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Minoryx Therapeutics have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.